Journals / Journal of Health Sciences and Medicine / 2021 / Cilt: 4 - Sayı: 3

A key challenge in gestational diabetes screening: resistance to oral glucose tolerance test screening and implications for neonatal health

Pages
262–266
Publication Date
2021-05-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The cesarean (C/S) delivery rate was significantly lower in the babies of mothers who did not have the OGTT test (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Gestational diabetes mellitus (GDM) is the most common endocrine disorder in pregnancy and the number of pregnant women resistant to oral glucose tolerance test (OGTT) has increased significantly in recent years.
📊
Key Findings & Data:Material and Method: Pregnant women and their babies who were followed up regularly for 25 months (December 1, 2015- December 31, 2017) in the obstetrics and gynecology clinic of our hospital were included in our study.
💡
Conclusion & Impact:Results: The cesarean (C/S) delivery rate was significantly lower in the babies of mothers who did not have the OGTT test (p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Oral glucose tolerance test · OGTT · pregnancy

Abstract

Objective: Gestational diabetes mellitus (GDM) is the most common endocrine disorder in pregnancy and the number of pregnant women resistant to oral glucose tolerance test (OGTT) has increased significantly in recent years. In this study, we investigated the extent of resistance to OGTT screening in pregnant women followed-up in our hospital and the effect of this situation on the newborn. Material and Method: Pregnant women and their babies who were followed up regularly for 25 months (December 1, 2015- December 31, 2017) in the obstetrics and gynecology clinic of our hospital were included in our study. The relationship between OGTT and clinicopathological findings was analyzed. Results: The cesarean (C/S) delivery rate was significantly lower in the babies of mothers who did not have the OGTT test (p

🔖

Cite This Article

TURSUN, S., YERAL, İ., YILDIZ, V., ÜNAL, E., GUZOGLU, N., ALİEFENDİOĞLU, D. (2021). A key challenge in gestational diabetes screening: resistance to oral glucose tolerance test screening and implications for neonatal health. Journal of Health Sciences and Medicine, Cilt: 4 - Sayı: 3, 262–266. https://ajindex.com/articles/776915

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Sert UY, Ozgu-Erdinc AS. Gestational diabetes mellitus screening and diagnosis. Adv Exp Med Biol 2021; 1307: 231-55.
  2. Lende M, Rijhsinghani A. Gestational diabetes: overview with emphasis on medical management. Int J Environ Res Public Health 2020; 17: 9573. Casey BM, Rice MM, Landon MB, et al. Effect of treatment of mild gestational diabetes on long-term maternal outcomes. Am J Perinatol 2020; 37: 475-82.
  3. Eunice Kennedy Shriver, National Institute of Child Health and Human Development. Maternal-Fetal Medicine Units (MFMU) Network. Available on https://mfmunetwork.bsc.gwu.edu/PublicBSC/MFMU/MFMUPublic/, Access date: 2020.
  4. Thayer SM, Lo JO, Caughey AB. Gestational diabetes: importance of follow-up screening for the benefit of long-term health. Obstet Gynecol Clin North Am 2020; 47: 383-96.
  5. Li YX, Long DL, Liu J, et al. Gestational diabetes mellitus in women increased the risk of neonatal infection via inflammation and autophagy in the placenta. Medicine (Baltimore) 2020; 99: e22152. Akgol S, Obut M, Baglı İ, et al. An evaluation of the effect of a one or two-step gestational diabetes mellitus screening program on obstetric and neonatal outcomes in pregnancies. Gynecol Obstet Reprod Med 2019; 25: 62–6.
  6. Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676-82.
  7. Chan A, King JF, Flenady V, et al. Classification of perinatal deaths: development of the Australian and New Zealand classifications. J Paediatr Child Health 2004; 40: 340-7.
  8. Metzger BE, Lowe LP et al. HAPO Study Cooperative Research Group, Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991–2001.
  9. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes on pregnancy outcomes. N Engl J Med 2005; 352: 2477-86.
  10. Landon MB, Thom E, Spong CY, et al. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Network randomized clinical trial in progress: standard therapy versus no therapy for mild gestational diabetes. Diabetes Care 2007; 30: 194-9.
  11. Karagöl BS, Karadag N, Zenciroglu A, et al. Yenidoğan yoğun bakımında yedi yıllık diyabetik anne bebeği deneyimi. Çocuk Derg 2012; 12: 169-76.
  12. Başbuğ A, Kaya AE, Sönmez Cİ, et al. Gestasyonel diyabet taramasında karşılaşılan önemli bir problem: Ge